LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lollipop-Based Saliva Collection System Could Become New Gold Standard for Disease Diagnostics

By LabMedica International staff writers
Posted on 12 Jul 2023
Print article
Image: CandyCollect could replace throat swabs to diagnose respiratory illnesses (Photo courtesy of University of Washington)
Image: CandyCollect could replace throat swabs to diagnose respiratory illnesses (Photo courtesy of University of Washington)

Throat swabs are routinely used to obtain samples for the diagnosis of a wide variety of disorders, including strep throat. Saliva sampling, in which technicians analyze a patient’s spit using methods such as quantitative polymerase chain reaction (qPCR), is a less-gag-inducing procedure. This approach is useful for at-home testing and saw greater use during the COVID-19 epidemic as this type of sample can be taken directly by a patient. However, collecting the required amount of saliva can be quite a distasteful experience. As a result, some scientists are aiming to make the process more delightful by mixing it with the equally drool-filled, though far more pleasant, experience of eating a lollipop.

Researchers at University of Washington (Seattle, WA, USA) have demonstrated for the first time that a lollipop-based saliva collection system is capable of capturing bacteria from adults and can remain shelf-stable for almost a year. CandyCollect, the lollipop collection device previously developed by the researchers, appears similar to a lollipop but features a spoon-like stick with a spiral-shaped groove carved into the top. This flattened end covered with isomalt candy enables saliva to easily flow into the groove as the lollipop is eaten. In an earlier study, the researchers had conducted lab tests that demonstrated CandyCollect was capable of capturing the bacteria causing strep throat. This time, the team focused on other naturally occurring bacteria and compared how CandyCollect performed among real people relative to other at-home saliva sampling methods available in the market.

The study involved 28 adult volunteers who received CandyCollect along with two conventional saliva sampling kits. After using them, the participants sent the devices back to the lab along with answers to specific survey questions. The research team eluted the samples and then quantified Streptococcus mutans and Staphylococcus aureus bacteria employing qPCR. They found that every time one or both of the conventional methods detected the target bacteria, CandyCollect was also successful in detecting them each time. The study participants also showed a greater preference for candies over conventional collection systems. CandyCollect was the most popular method out of the three devices among the volunteers who agreed that it was the “most sanitary” and “least disgusting.” Additionally, CandyCollect generated accurate results after being stored for a year. The findings suggest that CandyCollect is adaptable and preferred, but will continue to undergo further studies and could encourage others to design similar intuitive and easy-to-use at-home testing methods.

Related Links:
University of Washington 

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.